Document is current
Any future updates will be listed below
-
Authors
Leib, D. E.
Chen, Y. H.
Tecedor, L. https://orcid.org/0000-0001-7101-3544
Ranum, P. T.
Keiser, M. S. https://orcid.org/0009-0005-9055-6874
Lewandowski, B. C.
Carrell, E. M.
Arora, S.
Huerta-Ocampo, I.
Lai, D. https://orcid.org/0000-0002-4203-3391
Fluta, C. M.
Cheng, C.
Liu, X.
Davidson, B. L.
-
Funding
Funding for this research was provided by:
Children's Hospital of Philadelphia
- License Information
-
More Information
Article History
Received: 24 September 2024
Accepted: 8 May 2025
First Online: 19 May 2025
Competing interests
: L.T., Y.H.C., D.E.L., P.T.R., M.S.K., and B.L.D. are founders of Latus Bio and have stock options. D.E.L. and P.T.R. are employees of Latus Bio. B.L.D. has sponsored research or serves an advisory role for Carbon Bio, Resilience, Roche and Latus Bio. The other authors declare that they have no competing interests. A patent has been submitted; PCT/US2023/021905, ‘Adeno-associated viral vectors for targeting deep brain structures’, B.L.D., P.T.R., M.S.K., Y.H.C., L.T., and D.E.L.
